Mannatech Inc (MTEX) stock
MTEXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/3045% below fair value
$6.30−2.68 (-29.84%)
Close on Nov 13, 2026Market cap $12.16MP/E –Yield –
Mannatech ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Mannatech's ebitda for the twelve months ending Sep 30, 2026 was $1.96M, up 9.6% year over year. For fiscal 2025 it was $666.00K, down 77.5% from the year before. Over ten years it grew -26.2% a year on average. The highest annual figure on record is $17.85M in fiscal 2007.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $666.00K | -77.5% |
| FY2024 | Dec 31, 2024 | $2.96M | +346.2% |
| FY2023 | Dec 31, 2023 | $664.00K | -45.7% |
| FY2022 | Dec 31, 2022 | $1.22M | -88.7% |
| FY2021 | Dec 31, 2021 | $10.77M | +66.1% |
| FY2020 | Dec 31, 2020 | $6.48M | -23.9% |
| FY2019 | Dec 31, 2019 | $8.52M | +331.7% |
| FY2018 | Dec 31, 2018 | $1.97M | -55.0% |
| FY2017 | Dec 31, 2017 | $4.38M | +71.3% |
| FY2016 | Dec 31, 2016 | $2.56M | -81.6% |
| FY2015 | Dec 31, 2015 | $13.94M | -2.9% |
| FY2014 | Dec 31, 2014 | $14.35M | +108.7% |
| FY2013 | Dec 31, 2013 | $6.88M | +82.1% |
| FY2012 | Dec 31, 2012 | $3.78M | – |
| FY2011 | Dec 31, 2011 | -$6.19M | -17300.0% |
| FY2010 | Dec 31, 2010 | $36.00K | – |
| FY2009 | Dec 31, 2009 | -$13.26M | – |
| FY2008 | Dec 31, 2008 | -$2.19M | -112.3% |
| FY2007 | Dec 31, 2007 | $17.85M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $518.00K | -77.2% |
| Q2 FY2026 | Jun 30, 2026 | $1.26M | – |
| Q1 FY2026 | Mar 31, 2026 | $81.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $103.00K | -91.6% |
| Q3 FY2025 | Sep 30, 2025 | $2.27M | +76.2% |
| Q2 FY2025 | Jun 30, 2025 | -$1.17M | – |
| Q1 FY2025 | Mar 31, 2025 | -$540.00K | -143.7% |
| Q4 FY2024 | Dec 31, 2024 | $1.22M | – |
| Q3 FY2024 | Sep 30, 2024 | $1.29M | +106.9% |
| Q2 FY2024 | Jun 30, 2024 | -$743.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $1.24M | +12.4% |
| Q4 FY2023 | Dec 31, 2023 | -$491.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $622.00K | -70.0% |
| Q2 FY2023 | Jun 30, 2023 | -$567.00K | -149.1% |
| Q1 FY2023 | Mar 31, 2023 | $1.10M | +199.7% |
| Q4 FY2022 | Dec 31, 2022 | -$2.37M | -196.4% |
| Q3 FY2022 | Sep 30, 2022 | $2.07M | -37.2% |
| Q2 FY2022 | Jun 30, 2022 | $1.15M | +154.2% |
| Q1 FY2022 | Mar 31, 2022 | $367.00K | -80.1% |
| Q2 FY2021 | Jun 30, 2021 | $2.46M | +49.4% |
| Q1 FY2021 | Mar 31, 2021 | $3.30M | +30.3% |
| Q4 FY2020 | Dec 31, 2020 | $454.00K | -86.0% |
| Q3 FY2020 | Sep 30, 2020 | $1.85M | +70.5% |
| Q2 FY2020 | Jun 30, 2020 | $1.65M | -35.1% |
| Q1 FY2020 | Mar 31, 2020 | $2.53M | +53.6% |
| Q4 FY2019 | Dec 31, 2019 | $3.25M | +17021.1% |
| Q3 FY2019 | Sep 30, 2019 | $1.08M | -49.5% |
| Q2 FY2019 | Jun 30, 2019 | $2.54M | +1263.4% |
| Q1 FY2019 | Mar 31, 2019 | $1.65M | – |
| Q4 FY2018 | Dec 31, 2018 | $19.00K | -98.8% |
| Q3 FY2018 | Sep 30, 2018 | $2.15M | +93.6% |
| Q2 FY2018 | Jun 30, 2018 | $186.00K | -94.3% |
| Q1 FY2018 | Mar 31, 2018 | -$377.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $1.54M | +663.7% |
| Q3 FY2017 | Sep 30, 2017 | $1.11M | +9.3% |
| Q2 FY2017 | Jun 30, 2017 | $3.27M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.53M | – |
| Q4 FY2016 | Dec 31, 2016 | $201.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $1.01M | – |
See a number that looks wrong?